Pravin Dugel $OCUL SEC Form 4 Insider Trading

Pravin Dugel has filed a total of 4 insider trades in $OCUL since 2021. Their most recent trade was a sale of 21,475 shares, made on Feb 24, 2025. Their largest trade was a sale of 21,626 shares, made on May 23, 2024. We estimate that they now own 3.5 million shares of $OCUL, worth an estimated $24.2 million.

Insider Trading at $OCUL

There have been a total of 57 insider trades reported at $OCUL since 2021, with 3.0 million shares purchased and 255,866 shares sold. The most active insider traders in $OCUL stock have been Antony C. Mattessich, Pravin Dugel, and Rabia Gurses Ozden. The most recent trade was a sale of 21,475 shares reported by Pravin Dugel (See Remarks), made on Feb 24, 2025.

$OCUL Executives and Stock Owners with Insider Trades

• Antony C. Mattessich, President and CEO

• Pravin Dugel, See Remarks

• Rabia Gurses Ozden, Chief Medical Officer

• Sanjay Nayak, Chief Strategy Officer

• Christopher G White, Chief Business Officer

• Donald Notman, Chief Financial Officer

• Philip C. Strassburger, General Counsel

• Donald Notman, See Remarks

• Jeffrey S. Heier, Chief Scientific Officer

• Peter Kaiser, Chief Development Officer

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.